MoneyWorks4Me

Kabra Drugs informs about board meeting

22 Dec 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kabra Drugs has informed that a meeting of the Board of Directors of is scheduled to be held on Thursday 1 January 2026, at the Corporate office at Chennai of the Company, inter alia, to consider and approve the following strategic business items: 1. Change of Name of the Company 2. Strategic Acquisitions 3. Alteration of the Main Objects (MOA) 4. Any other agenda with the permission of the chair.

The above information is a part of company’s filings submitted to BSE.


Aanjaay Industries Share Price

24.98 0.80 (3.31%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: